NeoCura has secured 500 million yuan ($78 million) Series A+ capital. In a separate development, Xiaomi has led a funding round in AI medical management platform Synapsor.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
